Benjamin L. Maughan,
MD, PharmD
Languages Spoken: English
Benjamin Maughan MD, PharmD is an Assistant Professor in the Division of Medical Oncology at Huntsman Cancer Institute specializing in genitourinary malignancies. Dr. Maughan completed his PharmD, cum laude, from Idaho State University in 2004, then completed an oncology pharmacy residency at Mountain States Tumor Institute in 2005. Dr. Maughan earned his MD, cum laude, from the University of Kentucky, College of Medicine in 2010. He finished his Internal Medicine residency training with the University of Utah in 2013 and subsequently completed his medical oncology fellowship at Johns Hopkins in 2016. He has been awarded the Huntsman Cancer Institute Translational Scholar Award in 2019, and was selected for the 2019 SWOG Young Investigator Training Course.
Dr. Maughan has clinical and research interests in all genitourinary oncology, with a particular focus on the development of novel therapeutics and in identification of predictive biomarkers. During fellowship he studied predictive biomarkers in metastatic prostate cancer, specifically the role of truncated androgen receptors (AR-V7 expression) and loss of tumor suppressors (PTEN and Rb). More recently he is studying predictive biomarkers to immune therapy combinations in kidney, bladder and prostate cancers. He is exploring novel immune therapy combinations including checkpoint inhibitors combined with radiation therapy (radium-223), oncolytic viruses (MVA-brachyury) and targeted therapies (such as cabozantinib).
He is the lead physician in a SWOG clinical trial exploring a novel treatment for patients with metastatic papillary kidney cancer.
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Oncology |
| Board Certification | American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Medical Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.2/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 17, 2021
FARMINGTON HEALTH CENTER
Dr. Maughn and Lindsey are always most thorough in explaining my test results, treatment options, and how to move forward. I know we have options for my treatment, but why change? I hit the jackpot with my care team here at Huntsman. For that reason I am in the process of moving all my healthcare needs to the U of U and Huntsman.
UofU Patient
May 01, 2021
FARMINGTON HEALTH CENTER
great
UofU Patient
April 19, 2021
FARMINGTON HEALTH CENTER
Visit couldn't have been any better.
UofU Patient
April 18, 2021
HUNTSMAN CANCER CENTER
top notch
UofU Patient
April 15, 2021
HUNTSMAN CANCER CENTER
good experience.
UofU Patient
April 13, 2021
FARMINGTON HEALTH CENTER
Once again Dr. Maughan was excellent in answering my questions and showing concern for my condition. I have already recommended him to others.
UofU Patient
March 27, 2021
HUNTSMAN CANCER CENTER
excellent care
UofU Patient
March 24, 2021
HUNTSMAN CANCER CENTER
Dr. Maughan Rocks!!!
UofU Patient
March 19, 2021
FARMINGTON HEALTH CENTER
Dr Maughan is definitely a realist, he provided us good guidance, is personable and professional.
UofU Patient
March 07, 2021
HUNTSMAN CANCER CENTER
Once again Dr. Maughan answered all my questions in a caring and clear way
UofU Patient
March 01, 2021
HUNTSMAN CANCER CENTER
I have felt very well taken care of during my visits. I appreciate the way things are explained to me and how they always ask me questions about my feelings and symptoms. They always make sure I understand all the test results and treatments. I trust Dr Maughn's team, all of them.
UofU Patient
February 03, 2021
FARMINGTON HEALTH CENTER
awesome
UofU Patient
January 23, 2021
HUNTSMAN CANCER CENTER
Lindsey was terrific.
UofU Patient
January 17, 2021
HUNTSMAN CANCER CENTER
Dr. Maughan knew his stuff
UofU Patient
January 12, 2021
FARMINGTON HEALTH CENTER
Dr Maughan is terrific
UofU Patient
December 28, 2020
HUNTSMAN CANCER CENTER
One of the very few MD's who actually listen and hear what I am saying. Thank you! I feel very fortunate to have a Dr. Maughan as my oncologist.
UofU Patient
December 18, 2020
HUNTSMAN CANCER CENTER
Maughan and Lindsey explain better than school and colleges! very down to earth
UofU Patient
December 15, 2020
HUNTSMAN CANCER CENTER
I have no complaints. your team is awesome, bottom to top
UofU Patient
December 03, 2020
HUNTSMAN CANCER CENTER
I was thoroughly impressed at the time, attention, and information I received from the entire care team
UofU Patient
November 29, 2020
FARMINGTON HEALTH CENTER
Always honest and upfront with me.
UofU Patient
November 20, 2020
HUNTSMAN CANCER CENTER
I trust Dr Maughan and his team to decide on changes and courses of treatment.
UofU Patient
November 09, 2020
HUNTSMAN CANCER CENTER
Once again, Dr. Maughan was superb in explaining the various issues, particularly concerning a possible drug trial at the University of Washington.
UofU Patient
November 08, 2020
FARMINGTON HEALTH CENTER
Discussion about my treatment was very good
UofU Patient
October 13, 2020
HUNTSMAN CANCER CENTER
I am always very comfortable with my visits with Dr Maughn. He always listens to my concerns and answers all my questions. When I leave I feel like I understand his decisions and reasons for any changes to my treatments.
UofU Patient
October 10, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan is excellent
UofU Patient
October 05, 2020
FARMINGTON HEALTH CENTER
This appointment was the initial planning meeting for my cancer and was explained very throughly and my questions were answered to my satisfaction.
UofU Patient
October 03, 2020
HUNTSMAN CANCER CENTER
Dr Maughan and his team are the best! They are very attentive and caring.
UofU Patient
October 03, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan is so kind and up to date on ALL knowledge. I love this man
UofU Patient
September 24, 2020
HUNTSMAN CANCER CENTER
Although I had an appointment with Dr. Maughan I saw his Nurse Practitioer. Dr. Maughan was, however, great to answer my concerns and questions via email. I like Dr. Maughan very much.
UofU Patient
September 17, 2020
FARMINGTON HEALTH CENTER
Dr, Maughan is always outstanding. I couldn't ask for better.
UofU Patient
September 15, 2020
HUNTSMAN CANCER CENTER
I really appreciate the way the Dr or Assistant explains all tests and all results with me. they are always willing to listen to my questions or comments or concerns and they deal with them respectfully. I feel very well cared for and most of all, I feel that my health and my well being is important to them. Having cancer is hard enough, I would hate to have physicians that act like I'm just a name on a chart and not a real person. That means so much to me with Dr Maughn and Lyndsay Maxwell, as well as thier assistants.
UofU Patient
September 15, 2020
FARMINGTON HEALTH CENTER
Dr Maughan and staff were very informative and helpful.
UofU Patient
September 12, 2020
HUNTSMAN CANCER CENTER
Dr. Lindsay Maxwell is the very best that you have at Huntsman to assist Dr. Maughan
UofU Patient
August 31, 2020
HUNTSMAN CANCER CENTER
excellent
UofU Patient
August 24, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan is saving my life! what more can I say
UofU Patient
August 24, 2020
HUNTSMAN CANCER CENTER
very good
UofU Patient
August 17, 2020
FARMINGTON HEALTH CENTER
Good
UofU Patient
August 10, 2020
FARMINGTON HEALTH CENTER
Dr. Maughn and the entire staff at the Huntsman Cancer Institute have been great. After almost two years of being seen there the staff feels like family. When I go to the site for lab work it feels very comfortable and we are all now on a first name basis.
UofU Patient
July 05, 2020
HUNTSMAN CANCER CENTER
excellent experience
UofU Patient
June 16, 2020
FARMINGTON HEALTH CENTER
Dr Maughan is always exactly right.
UofU Patient
June 04, 2020
FARMINGTON HEALTH CENTER
Dr. Maughan and his Team are simply the best in every category.
UofU Patient
May 02, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan is fantastic. he is superb at explaining the issues and the alternatives. he also shows great concern for the patient as a person
UofU Patient
April 29, 2020
FARMINGTON HEALTH CENTER
good
UofU Patient
April 27, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan ROCKS!!!!
UofU Patient
March 23, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan was excellent at his job...which I have learned is normal for him. I will be resuming my treatments at your Farmington Clinic and will still be with Dr. Maughan and hopefully Lindsay.
UofU Patient
March 22, 2020
HUNTSMAN CANCER CENTER
A+ service
UofU Patient
March 11, 2020
FARMINGTON HEALTH CENTER
doctor was relaxed and I could tell that he honestly cared about me personally. he stayed as long as we had questions and he gave beautiful answers, complete answers.
UofU Patient
February 29, 2020
HUNTSMAN CANCER CENTER
Dr Maugan is the best
UofU Patient
February 25, 2020
HUNTSMAN CANCER CENTER
Dr. Maughan was very good in all of these areas.
UofU Patient
February 11, 2020
HUNTSMAN CANCER CENTER
I have never ever been treated this good at any other facility
UofU Patient
February 05, 2020
FARMINGTON HEALTH CENTER
Dr Maughan and his staff are always beyond excellent.
UofU Patient
January 25, 2020
HUNTSMAN CANCER CENTER
the doctor is very professional
UofU Patient
December 31, 2019
HUNTSMAN CANCER CENTER
Very good experience
UofU Patient
December 23, 2019
FARMINGTON HEALTH CENTER
Dr Maughan and his new practical nurse, Lindsay and his nurse Courtney were all excellent. they are a great team
UofU Patient
November 30, 2019
HUNTSMAN CANCER CENTER
Awesome
UofU Patient
November 25, 2019
HUNTSMAN CANCER CENTER
Dr. Maughan is just the very best!!! Would always highly recommend him!
UofU Patient
November 01, 2019
FARMINGTON HEALTH CENTER
Excellent!
UofU Patient
October 29, 2019
HUNTSMAN CANCER CENTER
good
UofU Patient
October 28, 2019
HUNTSMAN CANCER CENTER
my doctor is the best!
UofU Patient
October 28, 2019
HUNTSMAN CANCER CENTER
Love Dr. Maughan's providers they have always treated my husband with the upmost respect and kindness. the knowledge that they have has been exceptional.
UofU Patient
October 13, 2019
HUNTSMAN CANCER CENTER
Wonderful Staff
UofU Patient
October 07, 2019
HUNTSMAN CANCER CENTER
This was the first time that we had Lindsey and she was incredible with my husband. Thank you to this amazing team that Dr. Maughan has.
UofU Patient
September 25, 2019
HUNTSMAN CANCER CENTER
my Doctor is the best!!!!
UofU Patient
September 25, 2019
FARMINGTON HEALTH CENTER
always the gold standard!
UofU Patient
September 22, 2019
HUNTSMAN CANCER CENTER
Great job! keep it going please
UofU Patient
September 18, 2019
FARMINGTON HEALTH CENTER
Once again Dr Maughan spent considerable time answering my questions and giving clear explanations.
UofU Patient
September 11, 2019
FARMINGTON HEALTH CENTER
there were no discussions of this nature
UofU Patient
September 09, 2019
HUNTSMAN CANCER CENTER
Wonderful Staffs
UofU Patient
August 30, 2019
FARMINGTON HEALTH CENTER
I appreciate how Dr Maughn explained everything so I could understand. He answered all our questions clearly and understood my anxiety about it all.
UofU Patient
August 28, 2019
HUNTSMAN CANCER CENTER
Just poor bad side manner on this day
UofU Patient
August 26, 2019
FARMINGTON HEALTH CENTER
Dr Maughan is excellent in every respect.
UofU Patient
August 26, 2019
HUNTSMAN CANCER CENTER
Dr Maughan is an amazing physician and I appreciate all that he is doing for me.
UofU Patient
August 12, 2019
HUNTSMAN CANCER CENTER
I came hoping for answers, I had so many questions. I like that I had my questions answered and was given good choices for a definite path forward
UofU Patient
August 08, 2019
FARMINGTON HEALTH CENTER
Dealing with prostate cancer has it's high's and low's. Everytime I share my concerns with Dr. Maughan he provides me with details on my treatment progress as well as other treatment options that are available to me as I deal with my cancer. Always puts me at ease.
UofU Patient
August 05, 2019
HUNTSMAN CANCER CENTER
Dr Maughan always answers questions and shows his concern for my cancer problems.
UofU Patient
August 04, 2019
HUNTSMAN CANCER CENTER
they all seam to care about my condition .
UofU Patient
July 28, 2019
FARMINGTON HEALTH CENTER
Dr. Maughan is a top rate physician-listens, knowledgeable, empathetic!
UofU Patient
July 27, 2019
HUNTSMAN CANCER CENTER
great people
UofU Patient
July 26, 2019
FARMINGTON HEALTH CENTER
good
UofU Patient
June 28, 2019
HUNTSMAN CANCER CENTER
As usual, Dr. Maughan was excellent at answering my questions and evidenced a concern for my well being.
UofU Patient
May 17, 2019
FARMINGTON HEALTH CENTER
dr Maugham is excellent
UofU Patient
April 07, 2019
FARMINGTON HEALTH CENTER
sincere concern
UofU Patient
April 06, 2019
HUNTSMAN CANCER CENTER
Explanation of medications was somewhat unclear primarily because there was so much information passed on to me by Dr. Maughan. It was difficult to grasp all of it so I went to the My Chart site and asked further clarification.
UofU Patient
March 26, 2019
FARMINGTON HEALTH CENTER
Dr. Maughan is THE MAN.
UofU Patient
March 15, 2019
FARMINGTON HEALTH CENTER
Doctor Maughan and the entire Huntsman Staff Doctors and Nurses are angles from god! They are all working from the same playbook as the level of care and compassion are top shelf! We wouldn't dream of going anywhere for our specialized healthcare other than University of Utah and Huntsman Cancer Institute.
UofU Patient
March 08, 2019
HUNTSMAN CANCER CENTER
Just love Dr. Maughan!!! The vert best.
UofU Patient
January 30, 2019
HUNTSMAN CANCER CENTER
Wish he had more time to spend with me during the exam. 10-15 min is not enough for a person like me not medically trained and has questions usually because of the discussions that we have in the exam period.
UofU Patient
January 16, 2019
HUNTSMAN CANCER CENTER
Nothing but praise for Dr. Maughan
UofU Patient
January 14, 2019
FARMINGTON HEALTH CENTER
The doctor did not seem well informed on my test results from my PET scan as he called a few days later with greater knowledge of what my condition really was and suggested, what I understood to be an experimental treatment. I asked for paperwork I have not yet received. The paperwork is to help me make a decision on whether or not I want the specific treatment or some iteration of the treatment.
UofU Patient
January 10, 2019
FARMINGTON HEALTH CENTER
good
UofU Patient
December 14, 2018
FARMINGTON HEALTH CENTER
Dr. Maughn is the best!
UofU Patient
December 07, 2018
HUNTSMAN CANCER CENTER
They were extremely professional courteous friendly and confident and very welcoming and very impressed with them
UofU Patient
December 05, 2018
HUNTSMAN CANCER CENTER
love all the doctors & staff
UofU Patient
November 30, 2018
HUNTSMAN CANCER CENTER
My Physician is the best!!! Always kind and helpful, and very upbeat and informative.
UofU Patient
November 26, 2018
FARMINGTON HEALTH CENTER
The doctor and nurse always show concern for my condition and answer any questions I have.
UofU Patient
November 09, 2018
FARMINGTON HEALTH CENTER
Showed concern about my feelings in delivering the bad news of the cancer spreading and treatment options. Don't think anyone could have done it better.
UofU Patient
October 29, 2018
FARMINGTON HEALTH CENTER
As always, Dr. Maughn is an exceptional physician who is also compassionate and caring. He explains issues and procedures is a clear and easily understood way.
UofU Patient
October 17, 2018
HUNTSMAN CANCER CENTER
my doctor takes time but I have cancer theres very little he can do except follow established protocol in treatment. wish he had better news sometimes.
UofU Patient
October 10, 2018
FARMINGTON HEALTH CENTER
Excellent
UofU Patient
October 07, 2018
HUNTSMAN CANCER CENTER
Once again Dr. Maughan was very generous with his time and great at answering my questions
UofU Patient
October 07, 2018
FARMINGTON HEALTH CENTER
Have recommended Dr Maughun to another patient.
UofU Patient
October 05, 2018
FARMINGTON HEALTH CENTER
good
UofU Patient
September 18, 2018
FARMINGTON HEALTH CENTER
Dr. Maughan is a brilliant Oncologist. He will be as great or even greater tham Dr. James Kushner was however, Dr. Maughan is humble, thank heavens.
UofU Patient
September 14, 2018
FARMINGTON HEALTH CENTER
Once again Dr. Maughan was exceptional. He took time to answer all of my questions and explained in terms I could understand the mechanics of how the drug worked on the cancer cells. It was very complicated, but now I have a pretty decent lay understanding.
UofU Patient
September 10, 2018
FARMINGTON HEALTH CENTER
Dr. Benjamin Maughan and his staff are top notch.
UofU Patient
September 10, 2018
FARMINGTON HEALTH CENTER
Dr. Maughan is very impressive. He has my total confidence.
UofU Patient
August 23, 2018
FARMINGTON HEALTH CENTER
The doctor is great and very up to date, and we talked about a plan and we haven't heard back from the office as of yet.
UofU Patient
July 15, 2018
FARMINGTON HEALTH CENTER
I would like to know more about what treatments to expect and when they will be and what effect they will have on me.
UofU Patient
July 14, 2018
FARMINGTON HEALTH CENTER
I had a number of options when selecting my care while fighting prostate cancer...I chose Huntsman. The reason was my complete confidence in Dr. Maughan, the staff's professionalism and genuine interest in seeing me get the best care possible. In every instance when I engaged the Mayo Clinic in Rochester, MN the treatment I am receiving from Dr. Maughan was exactly the protocol that would be followed by the doctors there.
UofU Patient
July 07, 2018
HUNTSMAN CANCER CENTER
We love Dr. Maughan. I appreciate how accessible he is to me. I am very careful, considerate, and judicious in this accessibility.
UofU Patient
June 22, 2018
very good visit.
UofU Patient
June 21, 2018
Dr. Maughan is very carrying and helped ease much of our worry.
UofU Patient
May 26, 2018
wonderful experience -- would recommend this provider very highly!!!
UofU Patient
May 20, 2018
very thorough and professional
UofU Patient
May 11, 2018
Once again Dr. Maughan was terrific. He is excellent at explaining my condition and my options. He also was very responsive to my follow-up questions via MyChart and in calling me after the visit.
UofU Patient
April 27, 2018
Just one thought. When a patient is there to receive important, and possible bad information, concerning their cancer, don't engage with idle chit chat with your staff or fail to look the patient in the eye. This gives the false impression that the news they are waiting to here is bad and you are buying time before offering the bad news.
UofU Patient
April 13, 2018
good
UofU Patient
April 08, 2018
Dr. Maughan and his staff are amazing and very professional. We have great confidence in Dr. Maughan and all he is doing for us. Whenever we attend an appointment, Diane is always so welcoming and cheerful.
UofU Patient
March 15, 2018
good
UofU Patient
March 07, 2018
Dr Maughn, PA Gerrard, Dr Maughn's assistants, all were most willing to spend the time with me i needed to help me understand treatment and answer questions.
UofU Patient
March 05, 2018
Dr. Maughan is absolutely amazing. He spent so much time with me and my family explaining everything to us and answering all of our questions. We never felt rushed and he displayed a great amount of care for our situation. He is extremely professional but at the same time personable and easy to talk to. He shows great confidence in his ability to treat you as a patient which therefore instills a greater feeling of confidence in the care you will receive as a patient. He is thorough in his work and makes sure that he only leaves the room once he has answered all of your questions and calmed any fears. My family and I feel blessed to have him as our oncologist and have a very positive outlook on receiving care from him.
UofU Patient
February 18, 2018
very thorough and caring
UofU Patient
February 05, 2018
every thing was extremely good!
UofU Patient
January 26, 2018
Dr. Moughn was very thorough and caring
UofU Patient
January 16, 2018
Once again, Dr. Maughan was excellent. He is especially gifted in explaining the issue(s). I told him he would make a good expert witness.
UofU Patient
January 16, 2018
have not started treatment as of yet, do see how that goes.
UofU Patient
January 05, 2018
the Huntsman team is extremely compassionate and considerate
UofU Patient
December 27, 2017
The team I work with here at Huntsman is terrific and I feel like I won the lottery with the care I am receiving. Everything and everyone is top notch.
UofU Patient
December 20, 2017
we liked him very much
UofU Patient
November 18, 2017
Above average communication skills
UofU Patient
November 17, 2017
Dr. Maughn is the best.
UofU Patient
November 14, 2017
I just felt like he was in a hurry and did not explain things well, but then he stayed to answer questions and explained things a little better as I probed. We probably made him run late because we were not there a half hour to do our labs. He did explain things so much better the first visit we had with him, and spent a lot more time with us that first time.
UofU Patient
November 13, 2017
we were so impressed and pleased. they all took so much time and care with a very hard time for us. very personal. very caring. very professional.
UofU Patient
November 07, 2017
As usual , Dr Maughan and his team were excellent .
UofU Patient
November 06, 2017
Tops in all categories!!
UofU Patient
November 02, 2017
Love Dr. Maughn
UofU Patient
October 14, 2017
amazing
UofU Patient
October 14, 2017
He needs to go over blood test results
UofU Patient
September 26, 2017
every one on staff very friendly and helpful
UofU Patient
September 24, 2017
Dr. Maughan is a very intelligent, confident, kind person.
UofU Patient
September 06, 2017
I am still waiting for the follow up phone call that was supposed to come on Wednesday, September 6th. I still haven't received it yet.
UofU Patient
September 04, 2017
Once again, Dr. Maughan was excellent. He spent considerable time with us and carefully explained the various trials and the options for future treatment.
UofU Patient
August 12, 2017
l'm still in the process of establishing a comfort level with this provider.
UofU Patient
July 22, 2017
Great doctor
UofU Patient
July 10, 2017
good
UofU Patient
June 28, 2017
under circumstances, amazing experience!~
UofU Patient
June 13, 2017
I hope all the follow ups are as efficient and friendly as our first!
UofU Patient
June 12, 2017
Dr. Maughan was excellent in every way. He took the necessary time to answer our questions, gave clear explanations and called me at 6 PM on a Saturday to report his conversations with Dr. Higano at the University of Washington to give me his recommendations. I greatly appreciate his care and concern.
UofU Patient
April 23, 2017
we already have recommended someone.
UofU Patient
April 16, 2017
Dr. Maughan was excellent. He gave us ample time and was very clear in his explanations.
UofU Patient
February 03, 2017
I only gave the two "good" answers because it was our first appointment
UofU Patient
January 10, 2017
Dr Maughan gave me as much time as needed to answer questions posed by my wife and I .Very pleased , very professional.
UofU Patient
December 27, 2016
all the staff very well trained and very concerned about my situation Dr. Maughn so young!!!!!HaHa
UofU Patient
December 17, 2016
Good experience.
UofU Patient
December 13, 2016
DR Maughan is very knowledgeable. He spoke to my level.
Benjamin Maughan MD, PharmD is an Assistant Professor in the Division of Medical Oncology at Huntsman Cancer Institute specializing in genitourinary malignancies. Dr. Maughan completed his PharmD, cum laude, from Idaho State University in 2004, then completed an oncology pharmacy residency at Mountain States Tumor Institute in 2005. Dr. Maughan earned his MD, cum laude, from the University of Kentucky, College of Medicine in 2010. He finished his Internal Medicine residency training with the University of Utah in 2013 and subsequently completed his medical oncology fellowship at Johns Hopkins in 2016. He has been awarded the Huntsman Cancer Institute Translational Scholar Award in 2019, and was selected for the 2019 SWOG Young Investigator Training Course.
Dr. Maughan has clinical and research interests in all genitourinary oncology, with a particular focus on the development of novel therapeutics and in identification of predictive biomarkers. During fellowship he studied predictive biomarkers in metastatic prostate cancer, specifically the role of truncated androgen receptors (AR-V7 expression) and loss of tumor suppressors (PTEN and Rb). More recently he is studying predictive biomarkers to immune therapy combinations in kidney, bladder and prostate cancers. He is exploring novel immune therapy combinations including checkpoint inhibitors combined with radiation therapy (radium-223), oncolytic viruses (MVA-brachyury) and targeted therapies (such as cabozantinib).
He is the lead physician in a SWOG clinical trial exploring a novel treatment for patients with metastatic papillary kidney cancer.
Academic Locations
Huntsman Cancer Hospital
801-585-0255
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Oncology |
| Board Certification | American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Medical Oncology) |
Research Interests
- Development of Predictive Biomarkers of Response to Therapy
- Novel Therapeutic Development in Genitourinary Cancers
- Molecular Diagnostics
- Immunotherapy in Genitourinary Cancers
Education History
| Fellowship | Johns Hopkins University Medical Oncology Fellow |
| Residency | University of Utah School of Medicine Internal Medicine Resident |
| Professional Medical | University of Kentucky College of Medicine Medicine M.D. |
| Residency | St. Luke's Mountain States Tumor Institute Oncology Pharmacy Resident |
| Doctoral Training | Idaho State University College of Pharmacy Pharmacy Pharm.D. |
Selected Publications - Journal Articles
Journal Article
- Swami U, Haaland B, Kessel A, Nussenzveig R, Maughan BL, Esther J, Sirohi D, Pal SK, Grivas P, Agarwal N (2020). Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma. J Urol, 205(3), 709-717.
- Sena LA, Fountain J, Isaacsson Velho P, Lim SJ, Wang H, Nizialek E, Rathi N, Nussenzveig R, Maughan BL, Velez MG, Ashkar R, Larson AC, Pritchard CC, Adra N, Bryce AH, Agarwal N, Pardoll DM, Eshleman JR, Lotan TL, Antonarakis ES (2020). Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer. Oncologist, 26(2), e270-e278.
- McKay RR, McGregor BA, Xie W, Braun DA, Wei X, Kyriakopoulos CE, Zakharia Y, Maughan BL, Rose TL, Stadler WM, McDermott DF, Harshman LC, Choueiri TK (2020). Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE). J Clin Oncol, 38(36), 4240-4248.
- Swami U, Isaacsson Velho P, Nussenzveig R, Chipman J, Sacristan Santos V, Erickson S, Dharmaraj D, Alva AS, Vaishampayan UN, Esther J, Hahn AW, Maughan BL, Antonarakis ES, Agarwal N (2020). Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol, 78(5), 652-656.
- Kaur H, Samarska I, Lu J, Faisal F, Maughan BL, Murali S, Asrani K, Alshalalfa M, Antonarakis ES, Epstein JI, Joshu CE, Schaeffer EM, Mosquera JM, Lotan TL (2020). Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance. Prostate, 80(12), 1012-1023.
- Armstrong JM, Martin CR, Dechet C, Morton K, Evans D, Ambrose J, Maughan BL, ONeil B, Lowrance W (2020). 18F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment. Urol Oncol, 38(7), 636.e1-636.e6.
- Vidula N, Rich TA, Sartor O, Yen J, Hardin A, Nance T, Lilly MB, Nezami MA, Patel SP, Carneiro BA, Fan AC, Brufsky AM, Parker BA, Bridges BB, Agarwal N, Maughan BL, Raymond VM, Fairclough SR, Lanman RB, Bardia A, Cristofanilli M (2020). Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors. Clin Cancer Res, 26(11), 2546-2555.
- Rathi N, Maughan BL, Agarwal N, Swami U (2020). Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma. Cancer Manag Res, 12, 3741-3749.
- Agarwal N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Gupta S, Batten J, Thorley J, Hawks J, Santos VS, Nachaegari G, Wang X, Boucher K, Haaland B, Maughan BL (2020). Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clin Cancer Res, 26(9), 2104-2110.
- Maughan BL, Antonarakis ES (2020). Does sequencing order of antiandrogens in prostate cancer matter? Nat Rev Urol, 17(4), 197-198.
- Boyle JL, Hahn AW, Kapron AL, Kohlmann W, Greenberg SE, Parnell TJ, Teerlink CC, Maughan BL, Feng BJ, Cannon-Albright L, Agarwal N, Cooney KA (2020). Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. JCO Precis Oncol, 4.
- Hahn AW, Drake C, Denmeade SR, Zakharia Y, Maughan BL, Kennedy E, Link C Jr, Vahanian N, Hammers H, Agarwal N (2019). A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma. Oncologist, 25(2), 121-e213.
- Antonarakis ES, Isaacsson Velho P, Fu W, Wang H, Agarwal N, Sacristan Santos V, Maughan BL, Pili R, Adra N, Sternberg CN, Vlachostergios PJ, Tagawa ST, Bryce AH, McNatty AL, Reichert ZR, Dreicer R, Sartor O, Lotan TL, Hussain M (2020). CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors. JCO Precis Oncol, 4, 370-381.
- Esther J, Dorff TB, Maughan BL (2020). Recent developments in the treatment of non-metastatic castration resistant prostate cancer. Cancer Treat Res Commun, 24, 100181.
- Nappi L, Thi M, Lum A, Huntsman D, Eigl BJ, Martin C, ONeil B, Maughan BL, Chi K, So A, Black PC, Gleave M, Wyatt AW, Lavoie JM, Khalaf D, Bell R, Daneshmand S, Hamilton RJ, Leao RRN, Nichols C, Kollmannsberger C (2019). Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum. J Clin Oncol, 37(33), 3090-3098.
- Hahn AW, Drake C, Denmeade SR, Zakharia Y, Maughan BL, Kennedy E, Link C Jr, Vahanian N, Hammers H, Agarwal N (2019). A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma. (Epub ahead of print) Oncologist.
- Esther J, Hale P, Hahn AW, Agarwal N, Maughan BL (2019). Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors. 36(5), 395-401.
- Hahn AW, Gill DM, Poole A, Nussenzveig RH, Wilson S, Farnham JM, Stephenson RA, Cannon-Albright LA, Maughan BL, Agarwal N (2018). Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC). Mol Cancer Ther, 18(3), 726-729.
- Esther J, Maughan BL, Anderson N, Agarwal N, Hahn AW (2019). Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction. Curr Treat Options Oncol, 20(2), 14.
- Stenehjem DD, Hahn AW, Gill DM, Albertson D, Gowrishankar B, Merriman J, Agarwal AM, Thodima V, Harrington EB, Au TH, Maughan BL, Houldsworth J, Pal SK, Agarwal N (2019). Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PLoS ONE, 14(1), e0210415.
- Twardowski P, Wong JYC, Pal SK, Maughan BL, Frankel PH, Franklin K, Junqueira M, Prajapati MR, Nachaegari G, Harwood D, Agarwal N (2018). Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer. Cancer Treat Res Commun, 19, 100116.
- Hahn AW, Stenehjem D, Nussenzveig R, Carroll E, Bailey E, Batten J, Maughan BL, Agarwal N (2019). Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time. Cancer Treat Res Commun, 19, 100120.
- Maughan BL, Pal SK, Gill D, Boucher K, Martin C, Salgia M, Nussenzveig R, Liu T, Hawks JL, Batten J, Nachaegari G, Stephenson R, Lowrance W, Jones J, Dechet C, Agarwal N (2018). Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial. Oncologist, 23(12), 1413-e151.
- Sirohi D, Smith SC, Agarwal N, Maughan BL (2018). Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities. Res Rep Urol, 10, 205-217.
- Maughan BL, Guedes LB, Boucher K, Rajoria G, Liu Z, Klimek S, Zoino R, Antonarakis ES, Lotan TL (2018). p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis, 21(2), 260-268.
- Gill DM, Hahn AW, Hale P, Maughan BL (2018). Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma. Curr Treat Options Oncol, 19(1), 6.
- Maughan BL, Guedes LB, Boucher K, Rajoria G, Liu Z, Klimek S, Zoino R, Antonarakis ES, Lotan TL (2018). p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis, 10.1038(s41391-017).
- Hahn AW, Gill DM, Agarwal N, Maughan BL (2017). PD-1 checkpoint inhibition: toxicities and management. Urol Oncol, 10.1016(35(12)), 701-701.
- Poole A, Gill D, Hahn AW, Johnson E, Carroll E, Boucher K, Nussenzveig R, Maughan B, Agarwal N (2017). Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer. Clin Genitourin Cancer, S1558-7673(10.1016/j.).
- Terada N, Maughan BL, Akamatsu S, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Antonarakis ES (2017). Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naive castration-resistant prostate cancer: The Kyoto-Baltimore collaboration. Int J Urol, 24(6), 441-448.
- Harshman LC, Werner L, Tripathi A, Wang X, Maughan BL, Antonarakis ES, Nakabayashi M, McKay R, Pomerantz M, Mucci LA, Taplin ME, Sweeney CJ, Lee GM, Kantoff PW (2017). The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate, 77(13)(10.1002/pr), 1303-1311.
- Maughan BL, Luber B, Nadal R, Antonarakis ES (2017). Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study. Prostate, 77(1), 33-40.
- Maughan BL, Suzman DL, Luber B, Wang H, Glavaris S, Hughes R, Sullivan R, Harb R, Boudadi K, Paller C, Eisenberger M, Demarzo A, Ross A, Antonarakis ES (2016). Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol, 78(6), 1297-1304.
- Maughan BL, Antonarakis ES (2015). Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer. Curr Treat Options Oncol, 16(12), 57.
- Maughan BL, Xhou XC, Suzman DL, Nadal R, Bassi S, Schweizer MT, Antonarakis ES (2015). Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer. Prostate, 75(15), 1814-20.
- Maughan BL, Antonarakis ES (2014). Enzalutamide in chemo-naive castration-resistant prostate cancer: effective for most but not for all. Asian J Androl, 16(6), 807-8.
- Agarwal N, Bellmunt J, Maughan BL, Boucher KM, Choueiri TK, Qu AQ, Vogelzang NJ, Fougeray R, Niegisch G, Albers P, Wong YN, Ko YJ, Sridhar SS, Tantravahi SK, Galsky MD, Petrylak DP, Vaishampayan UN, Mehta AN, Beer TM, Sternberg CN, Rosenberg JE, Sonpavde G (2014). Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma. Clin Genitourin Cancer, 12(2), 130-7.
- Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD, Sonpavde G (2013). Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma. Clin Genitourin Cancer, 11(3), 316-20.
- Patel JC, Maughan BL, Agarwal AM, Batten JA, Zhang TY, Agarwal N (2013). Emerging molecularly targeted therapies in castration refractory prostate cancer. Prostate Cancer, 2013, 981684.
Review
Case Report
Editorial
Letter
Abstract
- P Twardowski, J YCWong, SKPal, B LMaughan, P H Frankel, K Franklin, M Junqueira, M RPrajapati, G Nachaegari, D Harwood, N Agarwal (12/28/2018). Randomized phase II trial of Sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer [Abstract]. Cancer Treatment and Research Communications (doi: 10.1016/j.ctarc.2018.100116), 20 December 2018, 100116.
- Sirohi D, Smith SC, Agarwal N, Maughan BL (November 2018). Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities [Abstract]. Dove Medical Press, 2018(10), 205-217.
- Maughan BL, Suzman DL, Nadal R, Bassi S, Schweizer MT, Antonarakis ES (2015). Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC) [Abstract]. J Clin Oncol, 33(Suppl 7), abstr 252.